CoronaryAtlas logo
CoronaryAtlas
3-OMD
Pathway / Plaque inflammation

3-OMD

metabolite

3-OMD is a tryptophan metabolite elevated in plaque-rupture phenotype, marking inflammatory destabilization and MACE risk.

Pathway placement
Cascade stepPlaque inflammation
Confidencemedium
RationaleKynurenine metabolite elevated in plaque rupture; immune-inflammatory axis relevant to plaque destabilization.
Also acts inCap degradation / rupture
Druggability
Not assessed (no mapped human gene target).

Assay & specimen

Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Serum, plasma or urine
Collection tube
Serum separator (gold/red-top, SST) · Lithium heparin (green-top) · Sterile urine container
Method / principle
LC-MS/MS (targeted metabolomics) or enzymatic colorimetric where available
Reagent / substrate
Stable-isotope-labeled internal standard (MS); or enzyme-coupled Trinder reagent
Platform
LC-MS/MS; some automated chemistry
Turnaround · availability
Send-out / research · Specialized / research

Literature evidence(1)